Belharra
Belharra Biotech Cuts 21 Jobs Amid Industry-Wide Restructuring
Belharra Biotech, layoffs, chemoproteomics, biotech industry, restructuring
Belharra Therapeutics Reduces Workforce by 40%, Laying Off 21 Employees
Belharra Therapeutics, layoffs, workforce reduction, biotech industry, drug discovery
Sanofi Partners with Belharra to Tackle ‘Undruggable’ Immunology Targets in $700M Deal
Sanofi, Belharra Therapeutics, Immunology, Small Molecule Therapies, Chemoproteomics, Undruggable Targets